Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Neurotrope, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R21.htm
10-Q - FORM 10-Q FOR 10-31-2012 - Neurotrope, Inc.form_10-q.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R18.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER - Neurotrope, Inc.ex_31-2.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Neurotrope, Inc.ex_31-1.htm
EX-32 - SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER - Neurotrope, Inc.ex_32-1.htm
v2.4.0.6
Balance Sheets (USD $)
Oct. 31, 2012
Jan. 31, 2012
CURRENT ASSETS    
Cash and cash equivalents $ 1,924 $ 5,745
Total current assets 1,924 5,745
TOTAL ASSETS 1,924 5,745
CURRENT LIABILITIES    
Accounts payable and Accrued liabilities 36   
Note Payable 6,200   
Total liabilities 6,236   
STOCKHOLDERS' EQUITY (DEFICIENCY)    
Capital Stock (Note 4) Authorized: 300,000,000 common shares, $0.0001 par value. Issued and outstanding: 10,200,000 common shares at October 31, 2012 and January 31, 2012. 1,020 1,020
Additional paid-in capital 19,980 19,980
Deficit accumulated during the development stage (25,312) (15,255)
Total Stockholders' Equity (Deficiency) (4,312) 5,745
TOTAL LIABILITIES AND STOCKHOLDERS? EQUITY $ 1,924 $ 5,745